The α-Galactosyl Carbohydrate Epitope in Pathogenic Protozoa.

Area of Science:

• Glycoscience
• Immunology
• Parasitology

Background:

• The α-gal epitope (α-d-Galp-(1 → 3)-β-d-Galp-(1 → 4)-d-GlcNAc-R) is present in non-human mammals but absent in humans due to gene inactivation.
• Human antibodies target α-d-Galp-containing molecules from other species, a phenomenon driven by evolutionary changes.

Purpose of the Study:

• To review α-d-Galp-containing glycoconjugates in pathogenic protozoa like *Trypanosoma*, *Leishmania*, and *Plasmodium*.
• To discuss the synthesis and application of neoglycoconjugates as potential diagnostic tools and vaccine antigens.

Main Methods:

• Literature review of studies on α-gal epitopes in pathogenic protozoa.
• Analysis of glycan structures, particularly in *Trypanosoma cruzi*, *Plasmodium* sporozoites, and *Leishmania* glycoinositolphospholipids (GIPLs).
• Inclusion of information on chemical synthesis of α-gal trisaccharides and GIPL glycans.

Main Results:

• α-d-Galp structures were identified in infective stages of *Trypanosoma cruzi* and *Plasmodium* sporozoites.
• Distinct α-d-Galp linkages were observed in *Leishmania* GIPL glycans.
• Chemically synthesized neoglycoconjugates, including the Galili epitope, have been developed.

Conclusions:

• Pathogenic protozoa possess α-gal epitopes, presenting targets for immune responses.
• Synthesized neoglycoconjugates show promise as diagnostic markers and vaccine candidates against these parasites.
• Understanding α-gal structures in parasites is crucial for developing novel therapeutic strategies.